Aprogen Biologics Inc. (KRX:003060)
1,338.00
+3.00 (0.22%)
Nov 2, 2026, 3:30 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 21.66 billion as of November 2, 2026. It is the 38,232nd most valuable company in the world and the 2,355th biggest in South Korea. Its market cap has decreased by 80.14% in one year.
Market Cap
21.66B
Enterprise Value
283.26B
Revenue
86.18B
Global Rank
Country Rank
#2,355 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 21.66B, an increase of 581.54%. That is a compound annual growth rate of 6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 21.66B | -78.88% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dong Sung Bio Pharm.Co.,Ltd. | 109.09B |
| HANDOK | 106.27B |
| Jeil Pharma Holdings | 105.16B |
| Enzychem Lifesciences | 76.86B |
| Kukje Pharma | 72.58B |
| CKD Bio | 65.78B |
| Ildong Holdings | 65.66B |
| CMG Pharmaceutical | 61.77B |